FidoCure® Veterinary Team Blog
Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates from our team of experts and advisors
Mesothelioma Case Study: Heidi
With combination therapy that included targeted therapy guided by FidoCure® genomic sequencing, Heidi has survived over a year following her initial diagnosis of mesothelioma and is still going strong.
Telangiectatic Osteosarcoma Case Study: Scout
With a combination approach that included FidoCure® therapy, Scout has lived for 1.5 years after his initial diagnosis of telangiectatic osteosarcoma.
No Dog Left Behind: Plan of Action to Address Drug Shortages
As you are likely aware, global supply chain issues are causing shortages of crucial raw drug ingredients needed to produce targeted therapy medications. These shortages are having a significant impact on the veterinary compounding pharmacy industry, and we know that you, your patients and pet parents are feeling the effects.
We want you to know that the FidoCure® team shares your sense of urgency and we are working hard to ensure that no dog is left without the cancer treatments it needs.
Providing access to life-saving therapies is one of our core values, and we are committed to putting you and your patients first.
A Note of Thanks on World Veterinary Day: New AI Findings
As we celebrate World Veterinary Day, we would like to express our heartfelt appreciation to the entire veterinary community. We at FidoCure are proud to help serve your work and your patients with our precision medicine platform. You are the front line fighter of cancer in pets and we are honored to partner in this battle against cancer to improve the quality of life for countless dogs.
Genomics and the promise to transform cancer treatment on both ends of the leash: National DNA Day
I am thrilled to join you all in commemorating National DNA Day and the role that genomics, the foundation of precision medicine, play in the future of cancer treatment.